Morocco

Reimbursed Care Access

Morocco maintains a strict national control regime that criminalises possession, use, cultivation and trafficking of most classic psychedelics and psychotropic substances, while permitting medical use of certain controlled anesthetic agents (notably ketamine) within hospitals and clinical practice. There is no publicly documented national regulatory approval or reimbursed pathway for psychedelic-assisted therapies (psilocybin, MDMA, etc.); access is therefore effectively limited to approved medical practice for licensed drugs (e.g., ketamine as an anesthetic) or to authorised clinical research where applicable.